A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE)
Authors
Underwood, TraceyMcNamara, A. L.
Appelt, A.
Haviland, J. S.
Singers Sørensen, B.
Troost, E. G. C.
Affiliation
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UKIssue Date
2022
Metadata
Show full item recordAbstract
Recently, a number of clinical studies have explored links between possible Relative Biological Effectiveness (RBE) elevations and patient toxicities and/or image changes following proton therapy. Our objective was to perform a systematic review of such studies. We applied a "Problem [RBE], Intervention [Protons], Population [Patients], Outcome [Side effect]" search strategy to the PubMed database. From our search, we retrieved studies which: (a) performed novel voxel-wise analyses of patient effects versus physical dose and LET (n = 13), and (b) compared image changes between proton and photon cohorts with regard to proton RBE (n = 9). For each retrieved study, we extracted data regarding: primary tumour type; size of patient cohort; type of image change studied; image-registration method (deformable or rigid); LET calculation method, and statistical methodology. We compared and contrasted their methods in order to discuss the weight of clinical evidence for variable proton RBE. We concluded that clinical evidence for variable proton RBE remains statistically weak at present. Our principal recommendation is that proton centres and clinical trial teams collaborate to standardize follow-up protocols and statistical analysis methods, so that larger patient cohorts can ultimately be considered for RBE analyses.Citation
Sa Underwood T, McNamara AL, Appelt A, Haviland JS, Singers Sørensen B, Troost EGC. A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE). Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2022 Aug 18. PubMed PMID: 35988776. Epub 2022/08/22. eng.Journal
Radiotherapy and OncologyDOI
10.1016/j.radonc.2022.08.014PubMed ID
35988776Additional Links
https://dx.doi.org/10.1016/j.radonc.2022.08.014Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.radonc.2022.08.014
Scopus Count
Collections
Related articles
- A systematic review on the usage of averaged LET in radiation biology for particle therapy.
- Authors: Kalholm F, Grzanka L, Traneus E, Bassler N
- Issue date: 2021 Aug
- A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
- Authors: Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G
- Issue date: 2001
- Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
- Authors: Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Domen J, Tans A, Janssens S, Wickramasinghe D, Lannoy V, Horn SRA, Van den Bruel A, Cochrane COVID-19 Diagnostic Test Accuracy Group
- Issue date: 2022 May 20
- Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.
- Authors: Brown SJ, Carter GJ, Halliwell G, Brown K, Caswell R, Howarth E, Feder G, O'Doherty L
- Issue date: 2022 Oct 4
- Sertindole for schizophrenia.
- Authors: Lewis R, Bagnall AM, Leitner M
- Issue date: 2005 Jul 20